Researchers recently compared outcomes between patients who followed a 6-month weight-loss intervention program and those who received treatment as usual. Participants in the intervention group ...

Patients with multiple sclerosis (MS) who were receiving disease-modifying therapies were found to have rare occurrences of severe COVID-19 if they had received the vaccine, according to a study ...

In stable MS patients, stopping Ocrevus does not seem to increase the risk of disease activity or disability progression for ...

MS patients are about twice as likely to develop restless legs syndrome than those without the disease, according to a study in Spain.

Andrew N. Wilner, MD: This is Dr Andrew Wilner, reporting for Medscape. Today I have the pleasure of interviewing Dr John Carter, Associate Professor at the Mayo Clinic, and a specialist in multiple ...

RMAT designation is based on promising Phase 2 clinical data demonstrating NG01’s potential to reduce disability and ...

Sepsis is an alarmingly common cause behind ICU admissions in patients with multiple sclerosis (MS), a retrospective, population-based cohort study indicates. Furthermore, it contributes to a ...

In MS trials, investigators are steering those cells toward B‑cell populations that appear to be driving inflammation.

Decreases in daytime activity among adults with MS, indicated via accelerometers worn on their wrists, indicated later development of worse disability and brain atrophy, according to data published in ...

“This study found that having bladder problems was significantly associated with lower well-being in [people with] MS, particularly when considering OAB. Bowel problems, self-management of bladder ...

HealthDay News — For most patients with multiple sclerosis (MS), there is no increased risk for relapse after COVID-19 vaccination, according to a study published online August 14 in Neurology. Xavier ...

There is currently no cure for Multiple Sclerosis (MS). Patients rarely do well with no therapy at all, and it is generally recommended that patients with a confident diagnosis of MS begin treatment ...